WO1994000599A3 - Process for detection of neoplastic disease - Google Patents
Process for detection of neoplastic disease Download PDFInfo
- Publication number
- WO1994000599A3 WO1994000599A3 PCT/US1993/005703 US9305703W WO9400599A3 WO 1994000599 A3 WO1994000599 A3 WO 1994000599A3 US 9305703 W US9305703 W US 9305703W WO 9400599 A3 WO9400599 A3 WO 9400599A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- detection
- neoplastic disease
- detect
- present
- processes
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/50—Fibroblast growth factors [FGF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Oncology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69304331T DE69304331T2 (en) | 1992-06-18 | 1993-06-14 | METHOD FOR DETECTING NEOPLASTIC DISEASES |
EP93916537A EP0646182B1 (en) | 1992-06-18 | 1993-06-14 | Process for detection of neoplastic disease |
AU46354/93A AU686566B2 (en) | 1992-06-18 | 1993-06-14 | Process for detection of neoplastic disease |
GR960403208T GR3021817T3 (en) | 1992-06-18 | 1996-11-28 | Process for detection of neoplastic disease. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90064692A | 1992-06-18 | 1992-06-18 | |
US07/900,646 | 1992-06-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1994000599A2 WO1994000599A2 (en) | 1994-01-06 |
WO1994000599A3 true WO1994000599A3 (en) | 1994-02-17 |
Family
ID=25412867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1993/005703 WO1994000599A2 (en) | 1992-06-18 | 1993-06-14 | Process for detection of neoplastic disease |
Country Status (10)
Country | Link |
---|---|
US (1) | US5670323A (en) |
EP (1) | EP0646182B1 (en) |
AT (1) | ATE141958T1 (en) |
AU (1) | AU686566B2 (en) |
CA (1) | CA2136439A1 (en) |
DE (1) | DE69304331T2 (en) |
DK (1) | DK0646182T3 (en) |
ES (1) | ES2091018T3 (en) |
GR (1) | GR3021817T3 (en) |
WO (1) | WO1994000599A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6446194A (en) * | 1993-03-17 | 1994-10-11 | Whittier Institute For Diabetes And Endocrinology, The | Monoclonal antibodies specific for fibroblast growth factor receptors, immunotoxins, and use thereof |
US6323316B1 (en) | 1996-06-18 | 2001-11-27 | The United States Of America As Represented By The Secretary Of The Department Of And Human Services | Fibroblast growth factor receptor activating gene 1 and related compositions and methods |
WO1999035159A1 (en) * | 1998-01-08 | 1999-07-15 | Brigham & Women's Hospital, Inc. | Lymphoma/leukemia oncogene, oncoprotein and methods of use |
WO2005066211A2 (en) * | 2003-12-19 | 2005-07-21 | Five Prime Therapeutics, Inc. | Fibroblast growth factor receptors 1, 2, 3, and 4 as targets for therapeutic intervention |
JOP20190083A1 (en) | 2008-06-04 | 2017-06-16 | Amgen Inc | Fgf21 mutant fusion polypeptides and uses thereof |
EA201990619A1 (en) | 2008-10-10 | 2019-07-31 | Амген Инк. | FGF21 MUTANTS AND THEIR APPLICATION |
UY32607A (en) | 2009-05-05 | 2010-12-31 | Amgen Inc | MUTANTS OF FGF21 AND USES OF THE SAME |
EP2427207B1 (en) | 2009-05-05 | 2017-08-16 | Amgen, Inc | Fgf21 mutants and uses thereof |
CA2796055A1 (en) | 2010-04-15 | 2011-10-20 | Amgen Inc. | Human fgf receptor and .beta.-klotho binding proteins |
CN116323666A (en) | 2020-08-21 | 2023-06-23 | 建新公司 | FGFR3 antibodies and methods of use |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0341904A2 (en) * | 1988-05-09 | 1989-11-15 | Temple University of the Commonwealth System of Higher Education | Method for predicting the effectiveness of antineoplastic therapy in individual patients |
WO1991000916A2 (en) * | 1989-07-06 | 1991-01-24 | The Regents Of The University Of California | Receptors for fibroblast growth factors |
WO1991011459A1 (en) * | 1990-01-23 | 1991-08-08 | Farmitalia Carlo Erba S.R.L. | Extracellular form of the human fibroblast growth factor receptor |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0387777A3 (en) * | 1989-03-15 | 1992-01-02 | Takeda Chemical Industries, Ltd. | Method for detecting and measuring fgf and for diagnosis of tumor |
WO1992004918A1 (en) * | 1990-09-19 | 1992-04-02 | The Salk Institute For Biological Studies | Treatment of tumorigenic pathophysiological conditions with fgf-cytotoxic conjugates |
-
1993
- 1993-06-14 CA CA002136439A patent/CA2136439A1/en not_active Abandoned
- 1993-06-14 DK DK93916537.9T patent/DK0646182T3/en active
- 1993-06-14 DE DE69304331T patent/DE69304331T2/en not_active Expired - Fee Related
- 1993-06-14 AU AU46354/93A patent/AU686566B2/en not_active Ceased
- 1993-06-14 EP EP93916537A patent/EP0646182B1/en not_active Expired - Lifetime
- 1993-06-14 AT AT93916537T patent/ATE141958T1/en not_active IP Right Cessation
- 1993-06-14 ES ES93916537T patent/ES2091018T3/en not_active Expired - Lifetime
- 1993-06-14 WO PCT/US1993/005703 patent/WO1994000599A2/en active IP Right Grant
-
1995
- 1995-06-02 US US08/459,296 patent/US5670323A/en not_active Expired - Fee Related
-
1996
- 1996-11-28 GR GR960403208T patent/GR3021817T3/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0341904A2 (en) * | 1988-05-09 | 1989-11-15 | Temple University of the Commonwealth System of Higher Education | Method for predicting the effectiveness of antineoplastic therapy in individual patients |
WO1991000916A2 (en) * | 1989-07-06 | 1991-01-24 | The Regents Of The University Of California | Receptors for fibroblast growth factors |
WO1991011459A1 (en) * | 1990-01-23 | 1991-08-08 | Farmitalia Carlo Erba S.R.L. | Extracellular form of the human fibroblast growth factor receptor |
Non-Patent Citations (6)
Title |
---|
A. ISACCHI ET AL., NUCLEIC ACIDS RESEARCH, vol. 18, no. 7, 1990, ARLINGTON, VIRGINIA US, pages 1906 * |
D. BECKER ET AL., ONCOGENE, vol. 7, November 1992 (1992-11-01), pages 2303 - 2313 * |
J. PARTANEN ET AL., EMBO JOURNAL, vol. 10, no. 6, 1991, EYNSHAM, OXFORD GB, pages 1347 - 1354 * |
M. SENO ET AL.: "Two cDNAs encoding novel human FGF receptor", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1089, 1991, pages 244 - 246 * |
NOVA M P ET AL: "THE FIBROBLAST GROWTH FACTOR RECEPTOR AS A DIAGNOSTIC AGENT FOR MALIGNANT MELANOMA.", 30TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF DERMATOPATHOLOGY, SAN FRANCISCO, CALIFORNIA, USA, DECEMBER 2-4, 1992. J CUTANEOUS PATHOL 19 (6). 1992. 544. CODEN: JCUPBN ISSN: 0303-6987 * |
THEILLET C ET AL: "AMPLIFICATION OF FGF -RELATED GENES IN HUMAN TUMORS POSSIBLE INVOLVEMENT OF HST IN BREAST CARCINOMAS.", ONCOGENE 4 (7). 1989. 915-922. CODEN: ONCNES ISSN: 0950-9232 * |
Also Published As
Publication number | Publication date |
---|---|
CA2136439A1 (en) | 1994-01-06 |
US5670323A (en) | 1997-09-23 |
WO1994000599A2 (en) | 1994-01-06 |
EP0646182B1 (en) | 1996-08-28 |
EP0646182A1 (en) | 1995-04-05 |
ES2091018T3 (en) | 1996-10-16 |
DK0646182T3 (en) | 1996-09-16 |
ATE141958T1 (en) | 1996-09-15 |
DE69304331T2 (en) | 1997-01-16 |
AU686566B2 (en) | 1998-02-12 |
AU4635493A (en) | 1994-01-24 |
DE69304331D1 (en) | 1996-10-02 |
GR3021817T3 (en) | 1997-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1994000599A3 (en) | Process for detection of neoplastic disease | |
EP1325926A3 (en) | Metallocenes | |
FI891226A (en) | RESEPTORDETERMINANTER I ANTI-T-CELLER FOER BEHANDLING AV AUTOIMMUNSJUKDOM. | |
AU1689297A (en) | Chemokine receptors 88-2B(CKR-3) and 88C and their antibodies | |
CA2079585A1 (en) | Ligand for the neu gene product | |
ES2145015T3 (en) | SPECIFIC PROTEASES OF UBIQUITINE. | |
WO2000050088A3 (en) | Biotinylated-chemokine antibody complexes | |
CA2413156A1 (en) | Expression vectors | |
WO1996009386A3 (en) | Allelic variation of the serotonin 5ht2c receptor | |
Eveleth et al. | Internalization and cycling of nerve growth factor in PC12 cells: interconversion of type II (fast) and type I (slow) nerve growth factor receptors | |
EA200701282A1 (en) | PROCESS OF ALKYLATION WITH RECYCLING THE OUTPUT FLOW FROM A TANK FOR DEPRESSION | |
Tang et al. | Retention of a type II surface membrane protein in the endoplasmic reticulum by the Lys-Asp-Glu-Leu sequence. | |
ATE139260T1 (en) | DIAGNOSTIC GENES FOR DETECTING TOXOPLASMOSIS | |
PL375955A1 (en) | Monocyclopentadienyl complexes | |
Bayer et al. | Close similarity among streptavidin-like, biotin-binding proteins from Streptomyces | |
Gibbons et al. | A method for the separation of hybrids of chromatographically identical oligomeric proteins. Use of 3, 4, 5, 6-tetrahydrophthaloyl groups as a reversible" chromatographic handle" | |
DE3278505D1 (en) | Hybridoma antibody which inhibits interleukin-2 activity and its use as a reagent for interleukin-2 detection, the production of said antibody, a process for producing hybrid anti-interleukin-2 antibody producing cells, and such cells | |
AU4951797A (en) | Process for detecting live microbiological contaminants in food product sample | |
AU6991994A (en) | Prostaglandin receptor ep3 and dna encoding it | |
EP0036336A3 (en) | Process for detecting proteins specific to hypertension in mammals | |
WO1994012669A3 (en) | Detection of dna contaminants by pcr | |
WO2001034808A3 (en) | Method of large-scale production and method of testing of the biological activity of a substance from soybean | |
Haziot et al. | Biochemistry of HLA-DRw6: evidence for seven distinct haplotypes. | |
AU2003258599A8 (en) | Monocyclopentadienyl complexes | |
AU4501893A (en) | Flat roof duct |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AT AU BB BG BR CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AT AU BB BG BR CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2136439 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1993916537 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 1995 367311 Country of ref document: US Date of ref document: 19950113 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 1993916537 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
ENP | Entry into the national phase |
Ref document number: 1995 477231 Country of ref document: US Date of ref document: 19950607 Kind code of ref document: A |
|
WWG | Wipo information: grant in national office |
Ref document number: 1993916537 Country of ref document: EP |